HealthPhoto: Pharmaceutical TechnologyAmbrose Healthcare Strengthens Rare Disease Pipeline with AM-Pharma Acquisition
Ambrose Healthcare has expanded its rare disease portfolio by acquiring AM-Pharma. This move positions Ambrose to compete in launching new medicines on the HPP market as the only approved therapy nears critical patent expiries, potentially opening opportunities for new treatments.
Pharmaceutical Technology·




